News and Updates from the American Society of Clinical Oncology Annual Meeting
For the physicians treating men with non-metastatic castration resistant prostate cancer, knowing the risk of progression or death provides valuable information to guide the timing and selection of treatment.
Physicians and patients want to do everything possible to minimize the risk of breast cancer recurrence without incurring unnecessary toxicity from chemotherapy.
While guidelines for multiple myeloma advise pharmacologic prophylaxis to prevent development of venous thromboembolism (VTE) in high-risk patients, current risk assessment tools differ in the factors considered indicative of high risk and in the patients determined to need preventive anticoagulation.
Multiple organizations have recommended timely treatment for patients with lung cancer.
The treatment armamentarium for renal cell carcinoma and other genitourinary cancers continues to expand.
More than 95,000 Americans develop colon cancer, making it the third most common cancer in the U.S., excluding skin cancers.
Most people looking at a hospital room will see an environment specifically designed to keep human beings alive through even the most traumatic circumstances.
A facility-specific survey found that 138 of 140 VA facilities reported shortages of medical officers, with psychiatry and primary care positions being the most frequently listed.
The potential cost to the VA for lung disease associated with deployment to Iraq or Afghanistan shot up this year when an administrative law judge with the U.S. Department of Labor ruled that exposure to open-air burn pits caused a veteran’s lung disease.
VA Secretary nominee Robert L. Wilkie promised lawmakers he would not privatize VA healthcare if he is confirmed.
© 2000-2018. All Materials Copyright Marathon Medical Communications, Inc.